Insurance requirements like prior authorization and step therapy force patients to delay or abandon necessary eye care. The Academy is fighting against these harmful policies.
Image
Insurance companies increasingly stand between ophthalmologists and their patients. Prior authorization requirements force physicians to obtain insurer approval before delivering care that has already been deemed medically necessary — delaying treatment, consuming physician and staff time, and in some cases causing serious patient harm. Step therapy policies, also called "fail first" requirements, compel patients to try and fail on insurer-preferred drugs or treatments before accessing the care their physician has prescribed.
Together, these policies represent some of the most significant administrative burdens facing ophthalmology practices today. They are not clinically neutral: delays in treating conditions like age-related macular degeneration, glaucoma, and diabetic eye disease can result in permanent, irreversible vision loss.
The Academy has worked for years through legislation, regulation, and coalition advocacy to reform these policies and restore clinical decision-making authority to physicians and their patients.
Components
Prior Authorization
Intro Text / Subtitle
Health insurers require physicians to obtain pre-approval for treatments and tests, delaying patient care and burdening ophthalmology practices.
Step Therapy
Intro Text / Subtitle
"Fail first" policies force patients to try insurers' preferred drugs before accessing the treatments their physicians recommend.
Know Our Issues
These are the issues threatening ophthalmology and putting patient health at risk.
Take Action on Administrative Burden
Prior authorization and step therapy are harming your patients and burdening your practice. Congress can act — but only if physicians speak up.
CMS Tests Prior Authorization for Some ASC Services
The Centers for Medicare & Medicaid Services (CMS) has introduced a new pilot program requiring prior authorization (PA) for fee-for-service Medicare for certain services in ambulatory surgical centers (ASCs).
Member exclusive - Locked
Advocacy Works: CMS Delays ASC Prior Authorization Pilot
With the help of the American Society of Ophthalmic Plastic and Reconstructive Surgery, the Outpatient Ophthalmic Surgery Society, and the North American Neuro-Ophthalmology Society, the Academy has persuaded the Centers for Medicare & Medicaid Services (CMS) to delay the start of the prior authorization (PA) pilot in ambulatory surgical centers.
Member exclusive - Locked
Ophthalmology Coalition Pushes Back on CMS ASC Prior Authorization Pilot
The Academy is pushing for a delay in implementation for the pilot, scheduled to start on Dec. 15.
Our Advocacy in Action
The Academy continues to lead efforts to reduce administrative barriers that delay patient care and burden ophthalmology practices — securing regulatory wins and insurer corrections that directly benefit patients and physicians.
Medicare Advantage plans are delaying and denying care for ophthalmology patients through prior authorization, step therapy, and other administrative hurdles.
Drug Shortages
Intro Text / Subtitle
Ophthalmology's reliance on generic drugs and single-source suppliers leaves the specialty uniquely vulnerable to supply disruptions that can delay care and harm patients.
Medicare Physician Payment Reform
Intro Text / Subtitle
Decades of inadequate Medicare payment updates threaten ophthalmology practices' ability to serve patients and preserve their sight.